Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoThat compares to 55.6% for Keytruda alone. Earlier in the year, one analyst called results from the...
Is Moderna Stock a Buy Now That It's a 2-Product Company?
Motley Fool via Yahoo Finance· 6 days agovaccine. The company is sitting on a lot of cash, but it's also in expensive late-stage clinical...
Anixa Biosciences, Inc. (NASDAQ:ANIX) CFO Michael Catelani Acquires 6,250 Shares
ETF DAILY NEWS· 14 hours agoAnixa Biosciences, Inc. (NASDAQ:ANIX – Get Free Report) CFO Michael Catelani acquired 6,250 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The stock was acquired ...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 5 days agoIts recent price, though, suggests earnings will creep forward at a snail's pace. The stock has been...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoIt will be important to watch how Pfizer stock performs as the company shores up its pipeline and...
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 11 hours agoWeik Capital Management decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 26.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange ...
CNBC Daily Open: Opec extends cuts, Nvidia showcases new chip
CNBC· 7 days agoOPEC and it allies agreed to extend official crude production cuts into 2025 amid lackluster demand....
CNBC Daily Open: Dow drops on weak manufacturing data, GameStop soars
CNBC· 6 days agoTraders work as a screen displays the trading information for GameStop and AMC Theatres on the floor...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 2 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
Waterloo Capital L.P. Acquires Shares of 4,004 Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 12 hours agoWaterloo Capital L.P. bought a new position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange ...